pillbase.ru

Mayzent

Active substance: siponimod

siponimod fumaric acid

Centralised EU authorisationActive

Marketing holder: Novartis Europharm Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
  • siponimod fumaric acid
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 6
  • MAYZENT
    TABLET, FILM COATED · SIPONIMOD 2 mg/1
    0078-0986
    Novartis Pharmaceuticals Corporation
  • MAYZENT
    TABLET, FILM COATED · SIPONIMOD .25 mg/1
    0078-0979
    Novartis Pharmaceuticals Corporation
  • MAYZENT
    TABLET, FILM COATED · SIPONIMOD 1 mg/1
    0078-1014
    Novartis Pharmaceuticals Corporation
  • siponimod
    TABLET, FILM COATED · SIPONIMOD .25 mg/1
    17088-0177
    Novartis Pharma Stein AG
  • siponimod
    TABLET, FILM COATED · SIPONIMOD 1 mg/1
    17088-0184
    Novartis Pharma Stein AG
All products in this country (6)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-45c6-79dc-9ada-277a1ccb0731,01a12093-3c19-7aaf-81e9-9308a5314e28,01a12093-424b-7945-a17d-718157d63415,01a12097-eeb9-7318-85e0-7efb7c74fcb8,01a1209a-b893-792c-81eb-205207f3a52d;count=6 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004712
Registration status
Active
ATC code
L04
Sources
  • product · EMA · EMEA/H/C/004712 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004712 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004712 · Verified 2026-10-09